Titlebook: Combined Modality Therapy of Gastrointestinal Tract Cancer; Peter Schlag,Peter Hohenberger,Urs Metzger Conference proceedings 1988 Springe

受傷

Smoothing a Critical TransitionRadiotherapy is the usual treatment for inoperable esophageal carcinoma. Results published before 1976, when this trial was begun were very modest, except for those of Pearson [1], The 1-year survival rate varies from 15% to 30%, and 5-year survival rates were about 5% [2–7].

絕食

Smoothness Priors Analysis of Time SeriesIn an attempt to improve the conservative treatment of inoperable esophageal cancer we began 10 years ago to use the combined chemo-radiotherapy approach. Before conducting clinical trials we investigated the interaction of cytostatics and radiation in vitro on various cell lines.

antecedence

赤字

Ergots

過于光澤

Controlled Clinical Trial for the Treatment of Patients with Inoperable Esophageal Carcinoma: A StudRadiotherapy is the usual treatment for inoperable esophageal carcinoma. Results published before 1976, when this trial was begun were very modest, except for those of Pearson [1], The 1-year survival rate varies from 15% to 30%, and 5-year survival rates were about 5% [2–7].

lethal

你正派

Phase-III Clinical Trial of Adjuvant FAM2 (5-FU, Adriamycin and Mitomycin C) vs Control in ResectablDespite a reported decrease in incidence, gastric carcinoma remains a major oncologic problem in Western Europe. Surgery is at present the only hope for cure. The 5-year survival after curative surgery is about 40% for stage 2 and 20% for stage 3.

粗糙

Encoding

Preoperative Radiotherapy and Radical Surgery as Combined Treatment in Rectal CancerIn 1976, the Gastrointestinal Group of the EORTC activated a clinical trial on rectal cancer with the aim of studying the efficacy of high-dose preoperative irradiation therapy (34.5 Gy) as an adjuvant before radical surgery. This was a multicentric prospective phase-III clinical trial.